Katherine Jackman - Profile and Investment Details

Investor Profile

Katherine Jackman is a Venture Capital, Private Equity Firm, Investor based in Melbourne, Victoria, Australia with a diverse investment portfolio that includes companies such as QUE Oncology, Elastagen, Denteric, MecRx, Spinifex Pharmaceuticals, Allay Therapeutics, AstronauTx, Heart Metabolics, PolyActiva, Cardiora, Q-Sera, Okogen, NRG Therapeutics, Azura Ophthalmics Limited, Ena Respiratory, G I Therapies, Protego Medical, Vaxxas, Myricx Pharma, Signostics, EBR Systems, Auspherix, Solvanix, Phrenix Therapeutics, MetaBloQOccuRx, Global Kinetics Corporation, Aravax, Fibrotech Therapeutics, . Over time, Katherine Jackman has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Katherine Jackman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Immunotherapy, Healthcare Innovation, Life Science, Health Technology, Portfolio Management, Medical Technologies, Finance, Biotechnology, Medical Devices, Drug Development, Entrepreneurship, Health and Hospital Services, Neuroscience, Clinical Trials, Gene Therapy, Health Diagnostics, Medical, B2B, Therapeutics, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Katherine Jackman, as their portfolio suggests a familiarity and interest in this area.

Understanding Katherine Jackman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.